Answer
Riastap (human fibrinogen) is administered by intravenous injection or infusion after reconstitution and warming to room or body temperature, slowly at a comfortable rate not exceeding approximately 5 ml per minute, with treatment initiated under a physician experienced in coagulation disorders.
Sources for this answer
- Riastap 1gCSL Behring UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 10Document updated
Sources checked